Analysis of the antinociceptive interactions in two-drug combinations of gabapentin, oxcarbazepine and amitriptyline in streptozotocin-induced diabetic mice

European Journal of Pharmacology

Volumn 628, Issue 1-3, 2010, Pages 75-82

  Tomić, Maja A ^a   Vučković, Sonja M ^a   Stepanović Petrović, Radica M ^a   Micov, Ana M ^a   Ugrešić, Nenad D ^a   Prostran, Milica Š ^a   Bošković, Bogdan ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Amitriptyline; Diabetic neuropathy; Gabapentin; Oxcarbazepine; Streptozotocin; Synergistic interaction

Indexed keywords

AMITRIPTYLINE; AMITROLE; GABAPENTIN; OXCARBAZEPINE; STREPTOZOCIN;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; MALE; MONOTHERAPY; MOUSE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; TAIL FLICK TEST;

ADMINISTRATION, ORAL; AMINES; AMITRIPTYLINE; ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; CARBAMAZEPINE; CYCLOHEXANECARBOXYLIC ACIDS; DIABETES MELLITUS, EXPERIMENTAL; DRUG COMBINATIONS; DRUG INTERACTIONS; GAMMA-AMINOBUTYRIC ACID; MALE; MICE;

EID: 73749084644     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.11.016     Document Type: Article

References (55)

1. Ardid D., and Guilbaud G. Antinociceptive effects of acute and 'chronic' injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats. Pain 49 (1992) 279-287
2. Backonja M.M. Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus. Epilepsia 40 (1999) S57-S59 S73-S74
3. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., LaMoreaux L., and Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280 (1998) 1831-1836
4. Beydoun A., and Kutluay E. Oxcarbazepine. Expert Opin. Pharmacother. 3 (2002) 59-71
5. Beydoun A., Shaibani A., Hopwood M., and Wan Y. Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. Acta Neurol. Scand. 113 (2006) 395-404
6. Beyreuther B., Callizot N., and Stöhr T. Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy. Eur. J. Pharmacol. 539 (2006) 64-70
7. Bomholt S.F., Mikkelsen J.D., and Blackburn-Munro G. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology 48 (2005) 252-263
8. Calcutt N.A. Potential mechanisms of neuropathic pain in diabetes. Int. Rev. Neurobiol. 50 (2002) 205-228
9. Calcutt N.A., and Backonja M.M. Pathogenesis of pain in peripheral diabetic neuropathy. Curr. Diabetes Rep. 7 (2007) 429-434
10. Calcutt N.A., and Chaplan S.R. Spinal pharmacology of tactile allodynia in diabetic rats. Br. J. Pharmacol. 122 (1997) 1478-1482
11. Cheng J.K., and Chiou L.C. Mechanisms of the antinociceptive action of gabapentin. J. Pharmacol. Sci. 100 (2006) 471-486
12. Chong M.S., and Hester J. Diabetic painful neuropathy: current and future treatment options. Drugs 67 (2007) 569-585
13. Courteix C., Bardin M., Chantelauze C., Lavarenne J., and Eschalier A. Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics. Pain 57 (1994) 153-160
14. Craner M.J., Klein J.P., Renganathan M., Black J.A., and Waxman S.G. Changes of sodium channel expression in experimental painful diabetic neuropathy. Ann. Neurol. 52 (2002) 786-792
15. Dai X., Brunson C.D., Rockhold R.W., Loh H.H., Ho I.K., and Ma T. Gender differences in the antinociceptive effect of tramadol, alone or in combination with gabapentin, in mice. J. Biomed. Sci. 15 (2008) 645-651
16. Dogra S., Beydoun S., Mazzola J., Hopwood M., and Wan Y. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur. J. Pain 9 (2005) 543-554
17. Dost R., Rostock A., and Rundfeldt C. The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation. Naunyn Schmiedebergs Arch. Pharmacol. 369 (2004) 382-390
18. Fox A., Gentry C., Patel S., Kesingland A., and Bevan S. Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig. Pain 105 (2003) 355-362
19. Gaitan G., and Herrero J.F. Subeffective doses of dexketoprofen trometamol enhance the potency and duration of fentanyl antinociception. Br. J. Pharmacol. 135 (2002) 393-398
20. Gilron I., Bailey J.M., Tu D., Holden R.R., Weaver D.F., and Houlden R.L. Morphine, gabapentin, or their combination for neuropathic pain. N. Engl. J. Med. 352 (2005) 1324-1334
21. Gustafsson H., Flood K., Berge O.G., Brodin E., Olgart L., and Stiller C.O. Gabapentin reverses mechanical allodynia induced by sciatic nerve ischemia and formalin-induced nociception in mice. Exp. Neurol. 182 (2003) 427-434
22. Hanna M., O'Brien C., and Wilson M.C. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur. J. Pain 12 (2008) 804-813
23. Heughan C.E., and Sawynok J. The interaction between gabapentin and amitriptyline in the rat formalin test after systemic administration. Anesth. Analg. 94 (2002) 975-980
24. Hong S., Morrow T.J., Paulson P.E., Isom L.L., and Wiley J.W. Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin sensitive and resistant sodium channels in dorsal root ganglion neurons in the rat. J. Biol. Chem. 279 (2004) 29341-29350
25. Ichikawa K., Koyama N., Kiguchi S., Kojima M., and Yokota T. Inhibitory effect of oxcarbazepine on high-frequency firing in peripheral nerve fibers. Eur. J. Pharmacol. 420 (2001) 119-122
26. Jagodić M.M., Pathirathna S., Nelson M.T., Mancuso S., Joksović P.M., Rosenberg E.R., Bayliss D.A., Jevtović-Todorović V., and Todorović S.M. Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons. J. Neurosci. 27 (2007) 3305-3316
27. Jang Y., Kim E.S., Park S.S., Lee J., and Moon D.E. The suppressive effects of oxcarbazepine on mechanical and cold allodynia in a rat model of neuropathic pain. Anesth. Analg. 101 (2005) 800-806
28. Kamei J., Ohsawa M., Miyata S., and Tanaka S. Preventive effect of l-carnosine on changes in the thermal nociceptive threshold in streptozotocin-induced diabetic mice. Eur. J. Pharmacol. 600 (2008) 83-86
29. Khroyan T.V., Polgar W.E., Orduna J., Zaveri N.T., Judd A.K., Tuttle D.J., Sanchez A., and Toll L. Anti-nociceptive and anti-allodynic effects of a high affinity NOP hexapeptide [Ac-RY(3-Cl)YRWR-NH2] (Syn 1020) in rodents. Eur. J. Pharmacol. 560 (2007) 29-35
30. Kiguchi S., Imamura T., Ichikawa K., Kojima M., and Shibata N. Antinociceptive effect of oxcarbazepine (KIN-493/OCBZ) in diabetic animals and its pharmacological properties. Pharmacologist 44 (2002) A54
31. Kiguchi S., Imamura T., Ichikawa K., and Kojima M. Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy. Clin. Exp. Pharmacol. Physiol. 31 (2004) 57-64
32. Kissin I., Stanski D.R., Brown P.T., and Bradley Jr. E.L. Pentobarbital-morphine anesthetic interactions in terms of intensity of noxious stimulation required for arousal. Anesthesiology 78 (1993) 744-749
33. Latham J.R., Pathirathna S., Jagodić M.M., Choe W.J., Levin M.E., Nelson M.T., Lee W.Y., Krishnan K., Covey D.F., Todorović S.M., and Jevtović-Todorović V. Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice. Diabetes 58 (2009) 2656-2665
34. Le Bars D., Gozariu M., and Cadden S.W. Animal models of nociception. Pharmacol. Rev. 53 (2001) 597-652
35. Lindner M.D., Bourin C., Chen P., McElroy J.F., Leet J.E., Hogan J.B., Stock D.A., and Machet F. Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy. Exp. Clin. Psychopharmacol. 14 (2006) 42-51
36. Luszczki J.J., Andres M.M., and Czuczwar S.J. Synergistic interaction of gabapentin and oxcarbazepine in the mouse maximal electroshock seizure model-an isobolographic analysis. Eur. J. Pharmacol. 515 (2005) 54-61
37. Malmberg A.B., and Yaksh T.L. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology 79 (1993) 270-281
38. Max M.B., Culnane M., Schafer S.C., Gracely R.H., Walther D.J., Smoller B., and Dubner R. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 37 (1987) 589-596
39. Mellegers M.A., Furlan A.D., and Mailis A. Gabapentin for neuropathic pain: systematic review of controlled and uncontrolled literature. Clin. J. Pain 17 (2001) 284-295
40. Micó J.A., Ardid D., Berrocoso E., and Eschalier A. Antidepressants and pain. Trends Pharmacol. Sci. 27 (2006) 348-354
41. Morello C.M., Leckband S.G., Stoner C.P., Moorhouse D.F., and Sahagian G.A. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch. Intern. Med. 159 (1999) 1931-1937
42. Quintão N.L., Medeiros R., Santos A.R., Campos M.M., and Calixto J.B. The effects of diacerhein on mechanical allodynia in inflammatory and neuropathic models of nociception in mice. Anesth. Analg. 101 (2005) 1763-1769
43. Rojas-Corrales M.O., Casas J., Moreno-Brea M.R., Gibert-Rahola J., and Micó J.A. Antinociceptive effects of tricyclic antidepressants and their noradrenergic metabolites. Eur. Neuropsychopharmacol. 13 (2003) 355-363
44. Sullivan K.A., Lentz S.I., Roberts Jr. J.L., and Feldman E.L. Criteria for creating and assessing mouse models of diabetic neuropathy. Curr. Drug Targets 9 (2008) 3-13
45. Tallarida R.J. Drug Synergism and Dose-Effect Data Analysis. first ed. (2000), Chapman & Hall/CRC, Boca Raton
46. Tallarida R.J. The interaction index: a measure of drug synergism. Pain 98 (2002) 163-168
47. Tallarida R.J., and Murray R.B. Manual of Pharmacologic Calculations with Computer Programs. Second ed. (1986), Springer Verlag, New York
48. Tallarida R.J., Stone Jr. D.J., and Raffa R.B. Efficient designs for studying synergistic drug combinations. Life Sci. 6 (1997) 417-425
49. Taylor C.P. Mechanisms of analgesia by gabapentin and pregabalin - calcium channel alpha(2)-delta [Ca(v)alpha(2)-delta] ligands. Pain 142 (2009) 13-16
50. Ulugol A., Karadag H.C., Tamer M., Firat Z., Aslantas A., and Dokmeci I. Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats. Neurosci. Lett. 328 (2002) 129-132
51. Villetti G., Bergamaschi M., Bassani F., Bolzoni P.T., Maiorino M., Pietra C., Rondelli I., Chamiot-Clerc P., Simonato M., and Barbieri M. Antinociceptive activity of the N-methyl-d-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther. 306 (2003) 804-814
52. Vrethem M., Boivie J., Arnqvist H., Holmgren H., Lindström T., and Thorell L.H. A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin. J. Pain 13 (1997) 313-323
53. Yaksh T.L., Noueihed R.Y., and Durant P.A. Studies of the pharmacology and pathology of intrathecally administered 4-anilinopiperidine analogues and morphine in the rat and cat. Anesthesiology 64 (1986) 54-66
54. Yoon M.H., and Yaksh T.L. Evaluation of interaction between gabapentin and ibuprofen on the formalin test in rats. Anesthesiology 91 (1999) 1006-1013
55. Zin C.S., Nissen L.M., Smith M.T., O'Callaghan J.P., and Moore B.J. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy. CNS Drugs 22 (2008) 417-442